141 related articles for article (PubMed ID: 7607722)
1. Glucose metabolism in abdominally obese hypertensive and normotensive subjects.
O'Shaughnessy IM; Myers TJ; Stepniakowski K; Nazzaro P; Kelly TM; Hoffmann RG; Egan BM; Kissebah AH
Hypertension; 1995 Jul; 26(1):186-92. PubMed ID: 7607722
[TBL] [Abstract][Full Text] [Related]
2. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
[TBL] [Abstract][Full Text] [Related]
3. Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system.
Hennes MM; O'Shaughnessy IM; Kelly TM; LaBelle P; Egan BM; Kissebah AH
Hypertension; 1996 Jul; 28(1):120-6. PubMed ID: 8675251
[TBL] [Abstract][Full Text] [Related]
4. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
[TBL] [Abstract][Full Text] [Related]
5. Slower activation of insulin action in hypertension associated with obesity.
Biolo G; Toigo G; Ciocchi B; Situlin R; Guarnieri G
J Hypertens; 1998 Dec; 16(12 Pt 1):1783-8. PubMed ID: 9869012
[TBL] [Abstract][Full Text] [Related]
6. Insulin-induced hexokinase II expression is reduced in obesity and NIDDM.
Pendergrass M; Koval J; Vogt C; Yki-Jarvinen H; Iozzo P; Pipek R; Ardehali H; Printz R; Granner D; DeFronzo RA; Mandarino LJ
Diabetes; 1998 Mar; 47(3):387-94. PubMed ID: 9519744
[TBL] [Abstract][Full Text] [Related]
7. Obesity hypertension is related more to insulin's fatty acid than glucose action.
Egan BM; Hennes MM; Stepniakowski KT; O'Shaughnessy IM; Kissebah AH; Goodfriend TL
Hypertension; 1996 Mar; 27(3 Pt 2):723-8. PubMed ID: 8613231
[TBL] [Abstract][Full Text] [Related]
8. NIDDM in the elderly.
Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
[TBL] [Abstract][Full Text] [Related]
9. B cell secretion and insulin sensitivity in hypertensive and normotensive obese subjects.
Bonora E; Moghetti P; Zenere M; Tosi F; Travia D; Muggeo M
Int J Obes; 1990 Sep; 14(9):735-42. PubMed ID: 2228406
[TBL] [Abstract][Full Text] [Related]
10. Compensatory hyperinsulinemia and the forearm vasodilator response during an oral glucose-tolerance test in obese hypertensives.
Egan BM; Stepniakowski K
J Hypertens; 1994 Sep; 12(9):1061-7. PubMed ID: 7852750
[TBL] [Abstract][Full Text] [Related]
11. Obese men with type IIB hyperlipidemia are insulin resistant.
Karhapää P; Voutilainen E; Malkki M; Laakso M
Arterioscler Thromb; 1993 Oct; 13(10):1469-75. PubMed ID: 8399084
[TBL] [Abstract][Full Text] [Related]
12. The interaction of blood flow, insulin, and bradykinin in regulating glucose uptake in lower-body adipose tissue in lean and obese subjects.
Iozzo P; Viljanen A; Guzzardi MA; Laine H; Honka MJ; Ferrannini E; Nuutila P
J Clin Endocrinol Metab; 2012 Jul; 97(7):E1192-6. PubMed ID: 22523335
[TBL] [Abstract][Full Text] [Related]
13. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
Meneilly GS; Elliott T
Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
[TBL] [Abstract][Full Text] [Related]
14. Insulin does not reduce forearm alpha-vasoreactivity in obese hypertensive or lean normotensive men.
Neahring JM; Stepniakowski K; Greene AS; Egan BM
Hypertension; 1993 Oct; 22(4):584-90. PubMed ID: 8406664
[TBL] [Abstract][Full Text] [Related]
15. Insulin increases forearm vascular resistance in obese, insulin-resistant hypertensives.
Gudbjörnsdottir S; Elam M; Sellgren J; Anderson EA
J Hypertens; 1996 Jan; 14(1):91-7. PubMed ID: 12013500
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in hypertension is associated with body fat rather than blood pressure.
Toft I; Bønaa KH; Jenssen T
Hypertension; 1998 Jul; 32(1):115-22. PubMed ID: 9674647
[TBL] [Abstract][Full Text] [Related]
17. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
[TBL] [Abstract][Full Text] [Related]
18. Intracellular partition of plasma glucose disposal in hypertensive and normotensive subjects with type 2 diabetes mellitus.
Bonora E; Targher G; Alberiche M; Bonadonna RC; Zenere MB; Saggiani F; Muggeo M
J Clin Endocrinol Metab; 2001 May; 86(5):2073-9. PubMed ID: 11344209
[TBL] [Abstract][Full Text] [Related]
19. Co-existence of severe insulin resistance and hyperinsulinaemia in pre-adolescent obese children.
Caprio S; Bronson M; Sherwin RS; Rife F; Tamborlane WV
Diabetologia; 1996 Dec; 39(12):1489-97. PubMed ID: 8960831
[TBL] [Abstract][Full Text] [Related]
20. Impaired insulin sensitivity and maximal responsiveness in older hypertensive men.
Dengel DR; Pratley RE; Hagberg JM; Goldberg AP
Hypertension; 1994 Mar; 23(3):320-4. PubMed ID: 8125557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
